Intellia Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Thank you, everyone. My name is Gena Wang. I'm SMID-cap biotech analyst at Barclays. I first hope that everyone stay healthy, and I would like to thank all the participants, investors and companies, and especially our event team and corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our next presenter, John Leonard, President and the Chief Executive Officer from Intellia. Hi, John.
Hi, Gena. How are you?
Good, good. Maybe I will start with more of the big picture question. I know you don't have a slide for investors. Maybe wondering if you could just give us a quick overview of Intellia, so that would be helpful for those investors who are not familiar with the company.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
